department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

IDOSE TR · pharmadog

pharmadog
drugs
IDOSE TR

drug · small molecule

patient view →

IDOSE TR

updated 2mo ago

by $GKOS GLAUKOS Corp🔗 ChEMBL

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.

targets

Prostaglandin F2-alpha receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

IDOSE TR

trade names

Idose tr, Izba, Travatan, Travatan z, Travoprost, Travoprost component of duotrav

generic

TRAVOPROST

MOA

12.1 Mechanism of Action Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist, which is believed to reduce IOP by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.

indication

1 INDICATIONS AND USAGE iDose ® TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). iDose ® TR is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) ( 1 )

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 31m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 5

tagApproval42 co-mentions · 11 sources
drugtravoprost ER41 co-mentions · 11 sources
drugiLution travoprost41 co-mentions · 11 sources
drugTRAVATAN Z35 co-mentions · 11 sources
drugTRAVOPROST21 co-mentions · 11 sources

Trials studying IDOSE TR

phase4Travoprost Intraocular Implant + iStent Infiniterecruitingn=150
phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=510
phase3Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=610
—Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgrecruitingn=30
phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alonerecruitingn=132
phase4Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucomarecruitingn=20
phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)completedn=83
phase3Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%completedn=590

more trials →